| Reference |
|---|
Walter M, Mayr F, Hanna B, Cookson V, Mortusewicz O, Helleday T, et al. NUDT22 promotes cancer growth through pyrimidine salvage. Oncogene. 2023;42:1282-1293 pubmed publisher |
Preston A, Rogers A, Sharp M, Mitchell G, Toruno C, Barney B, et al. Elephant TP53-RETROGENE 9 induces transcription-independent apoptosis at the mitochondria. Cell Death Discov. 2023;9:66 pubmed publisher |
Iwai M, Kajino T, Nakatochi M, Yanagisawa K, Hosono Y, Isomura H, et al. Long non-coding RNA TILR constitutively represses TP53 and apoptosis in lung cancer. Oncogene. 2022;: pubmed publisher |
Liu Y, Wang X, Zhu W, Sui Z, Wei X, Zhang Y, et al. TRPML1-induced autophagy inhibition triggers mitochondrial mediated apoptosis. Cancer Lett. 2022;541:215752 pubmed publisher |
Lai S, Higuchi T, Tsuda M, Sugiyama Y, Morisawa K, Taniguchi T, et al. NF90-NF45 is essential for β cell compensation under obesity-inducing metabolic stress through suppression of p53 signaling pathway. Sci Rep. 2022;12:8837 pubmed publisher |
Haraoka Y, Akieda Y, Nagai Y, Mogi C, Ishitani T. Zebrafish imaging reveals TP53 mutation switching oncogene-induced senescence from suppressor to driver in primary tumorigenesis. Nat Commun. 2022;13:1417 pubmed publisher |
Humpton T, Hock A, Kiourtis C, de Donatis M, Fercoq F, Nixon C, et al. A noninvasive iRFP713 p53 reporter reveals dynamic p53 activity in response to irradiation and liver regeneration in vivo. Sci Signal. 2022;15:eabd9099 pubmed publisher |
Islam M, Junod S, Zhang S, Buuh Z, Guan Y, Zhao M, et al. Unprotected peptide macrocyclization and stapling via a fluorine-thiol displacement reaction. Nat Commun. 2022;13:350 pubmed publisher |
Wang B, Varela Eirin M, Brandenburg S, Hernandez Segura A, van Vliet T, Jongbloed E, et al. Pharmacological CDK4/6 inhibition reveals a p53-dependent senescent state with restricted toxicity. EMBO J. 2022;:e108946 pubmed publisher |
Xing Y, Wei X, Liu Y, Wang M, Sui Z, Wang X, et al. Autophagy inhibition mediated by MCOLN1/TRPML1 suppresses cancer metastasis via regulating a ROS-driven TP53/p53 pathway. Autophagy. 2021;:1-23 pubmed publisher |
Gudikote J, Cascone T, Poteete A, Sitthideatphaiboon P, Wu Q, Morikawa N, et al. Inhibition of nonsense-mediated decay rescues p53β/γ isoform expression and activates the p53 pathway in MDM2-overexpressing and select p53-mutant cancers. J Biol Chem. 2021;297:101163 pubmed publisher |
Giebel N, de Jaime Soguero A, García Del Arco A, Landry J, Tietje M, Villacorta L, et al. USP42 protects ZNRF3/RNF43 from R-spondin-dependent clearance and inhibits Wnt signalling. EMBO Rep. 2021;22:e51415 pubmed publisher |
Chi R, van der Watt P, Wei W, Birrer M, Leaner V. Inhibition of Kpnβ1 mediated nuclear import enhances cisplatin chemosensitivity in cervical cancer. BMC Cancer. 2021;21:106 pubmed publisher |
Kang M, Tang B, Li J, Zhou Z, Liu K, Wang R, et al. Identification of miPEP133 as a novel tumor-suppressor microprotein encoded by miR-34a pri-miRNA. Mol Cancer. 2020;19:143 pubmed publisher |
Kutle I, Szymańska de Wijs K, Bogdanow B, Cuvalo B, Steinbrück L, Jonjic S, et al. Murine Cytomegalovirus M25 Proteins Sequester the Tumor Suppressor Protein p53 in Nuclear Accumulations. J Virol. 2020;94: pubmed publisher |
Pelletier J, Riaño Canalias F, Almacellas E, Mauvezin C, Samino S, Feu S, et al. Nucleotide depletion reveals the impaired ribosome biogenesis checkpoint as a barrier against DNA damage. EMBO J. 2020;39:e103838 pubmed publisher |
Li Q, Hao Q, Cao W, Li J, Wu K, Elshimali Y, et al. PP2Cδ inhibits p300-mediated p53 acetylation via ATM/BRCA1 pathway to impede DNA damage response in breast cancer. Sci Adv. 2019;5:eaaw8417 pubmed publisher |
Carden S, van der Watt P, Chi A, Ajayi Smith A, Hadley K, Leaner V. A tight balance of Karyopherin β1 expression is required in cervical cancer cells. BMC Cancer. 2018;18:1123 pubmed publisher |
Wu K, Yu X, Huang Z, Zhu D, Yi X, Wu Y, et al. Targeting of PP2C? by a small molecule C23 inhibits high glucose-induced breast cancer progression in vivo. Antioxid Redox Signal. 2018;: pubmed publisher |
Zhu S, Chen Z, Wang L, Peng D, Belkhiri A, Lockhart A, et al. A Combination of SAHA and Quinacrine Is Effective in Inducing Cancer Cell Death in Upper Gastrointestinal Cancers. Clin Cancer Res. 2018;24:1905-1916 pubmed publisher |
Yang L, Li Y, Bhattacharya A, Zhang Y. PEPD is a pivotal regulator of p53 tumor suppressor. Nat Commun. 2017;8:2052 pubmed publisher |
Parvathaneni S, Lu X, Chaudhary R, Lal A, Madhusudan S, Sharma S. RECQ1 expression is upregulated in response to DNA damage and in a p53-dependent manner. Oncotarget. 2017;8:75924-75942 pubmed publisher |
Martínez Gil L, Vera Velasco N, Mingarro I. Exploring the Human-Nipah Virus Protein-Protein Interactome. J Virol. 2017;91: pubmed publisher |
Umezawa Y, Kurosu T, Akiyama H, Wu N, Nogami A, Nagao T, et al. Down regulation of Chk1 by p53 plays a role in synergistic induction of apoptosis by chemotherapeutics and inhibitors for Jak2 or BCR/ABL in hematopoietic cells. Oncotarget. 2016;7:44448-44461 pubmed publisher |
Upadhyay M, Bhadauriya P, Ganesh S. Heat shock modulates the subcellular localization, stability, and activity of HIPK2. Biochem Biophys Res Commun. 2016;472:580-4 pubmed publisher |
Wright D, Marchal C, Hoang K, Ankney J, Nguyen S, Rushing A, et al. Human T-cell leukemia virus type-1-encoded protein HBZ represses p53 function by inhibiting the acetyltransferase activity of p300/CBP and HBO1. Oncotarget. 2016;7:1687-706 pubmed publisher |
Lee W, Lee W, Cheng C, Chen K, Chou C, Chung C, et al. Repositioning antipsychotic chlorpromazine for treating colorectal cancer by inhibiting sirtuin 1. Oncotarget. 2015;6:27580-95 pubmed publisher |
Upadhyay M, Gupta S, Bhadauriya P, Ganesh S. Lafora disease proteins laforin and malin negatively regulate the HIPK2-p53 cell death pathway. Biochem Biophys Res Commun. 2015;464:106-11 pubmed publisher |
Nair B, Krishnan S, Sareddy G, Mann M, Xu B, Natarajan M, et al. Proline, glutamic acid and leucine-rich protein-1 is essential for optimal p53-mediated DNA damage response. Cell Death Differ. 2014;21:1409-18 pubmed publisher |
Yu X, Muñoz Alarcón A, Ajayi A, Webling K, Steinhof A, Langel U, et al. Inhibition of autophagy via p53-mediated disruption of ULK1 in a SCA7 polyglutamine disease model. J Mol Neurosci. 2013;50:586-99 pubmed publisher |
Heo K, Lee H, Nigro P, Thomas T, Le N, Chang E, et al. PKC? mediates disturbed flow-induced endothelial apoptosis via p53 SUMOylation. J Cell Biol. 2011;193:867-84 pubmed publisher |
He X, Ni Y, Wang Y, Romigh T, Eng C. Naturally occurring germline and tumor-associated mutations within the ATP-binding motifs of PTEN lead to oxidative damage of DNA associated with decreased nuclear p53. Hum Mol Genet. 2011;20:80-9 pubmed publisher |
O Driscoll C, Bressler J. Hairless expression attenuates apoptosis in a mouse model and the COS cell line; involvement of p53. PLoS ONE. 2010;5:e12911 pubmed publisher |
El Deiry W, Tokino T, Velculescu V, Levy D, Parsons R, Trent J, et al. WAF1, a potential mediator of p53 tumor suppression. Cell. 1993;75:817-25 pubmed |
